Summit Creek Advisors LLC Ligand Pharmaceuticals Inc Transaction History

Summit Creek Advisors LLC

$720 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 20, 2021	SELL	$99.52 - $215.83 $7.45 Million - $16.1 Million	-74,822 Closed	0 $0
Q4 2020 Jan 20, 2021	SELL	$80.55 - $106.05 $335,088 - $441,168	-4,160 Reduced 5.27%	74,822 $7.44 Million
Q3 2020 Oct 14, 2020	SELL	$89.56 - $126.72 $666,326 - $942,796	-7,440 Reduced 8.61%	78,982 $7.53 Million
Q2 2020 Jul 15, 2020	BUY	$68.28 - $123.65 $1.08 Million - $1.96 Million	15,840 Added 22.44%	86,422 $9.67 Million
Q1 2020 Apr 27, 2020	SELL	$63.37 - $107.88 $24,080 - $40,994	-380 Reduced 0.54%	70,582 $5.13 Million
Q4 2019 Jan 17, 2020	SELL	$96.94 - $113.59 $38,776 - $45,436	-400 Reduced 0.56%	70,962 $7.4 Million
Q3 2019 Oct 16, 2019	BUY	$86.25 - $120.16 $225,975 - $314,819	2,620 Added 3.81%	71,362 $7.1 Million
Q2 2019 Jul 19, 2019	BUY	$107.38 - $129.34 $2.27 Million - $2.74 Million	21,170 Added 44.5%	68,742 $7.85 Million
Q1 2019 Apr 15, 2019	SELL	$105.93 - $142.47 $8,474 - $11,397	-80 Reduced 0.17%	47,572 $5.98 Million
Q4 2018 Jan 15, 2019	BUY	$128.36 - $272.13 $2.51 Million - $5.32 Million	19,555 Added 69.6%	47,652 $6.47 Million
Q3 2018 Oct 11, 2018	SELL	$211.18 - $274.49 $4.71 Million - $6.12 Million	-22,290 Reduced 44.24%	28,097 $7.71 Million
Q2 2018 Jul 17, 2018	SELL	$150.77 - $207.98 $708,619 - $977,506	-4,700 Reduced 8.53%	50,387 $10.4 Million
Q1 2018 Apr 16, 2018	BUY	$138.63 - $182.62 $1.73 Million - $2.28 Million	12,510 Added 29.38%	55,087 $9.1 Million
Q4 2017 Jan 16, 2018	SELL	$128.36 - $147.04 $40,433 - $46,317	-315 Reduced 0.73%	42,577 $5.83 Million
Q3 2017 Oct 17, 2017	BUY	$120.91 - $137.94 $5.19 Million - $5.92 Million	42,892	42,892 $5.84 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Creek Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Creek Advisors LLC with notifications on news.

Account